Stocktoria
Glucotrack, Inc. GCTK
Glucotrack, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($46.70); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Glucotrack, Inc. trades at about 0× earnings — below its 10-year norm (10-year range 0×–1.0540541e+06×, median 26689.7×).
Shaded band = 10-year range (0×–1.0540541e+06×); dot = today's 0×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | — | 1685.6% | -0.0% | 1794.2% | -924.6% |
| Net margin | — | — | — | — | — | — | 1690.4% | -0.0% | 1752.2% | -884.4% |
| FCF margin | — | — | — | — | — | — | -1885.6% | -0.0% | -1003.4% | -880.9% |
| Return on assets | -247.4% | -380.9% | -144.7% | -181.9% | -64.9% | -25.4% | 320.8% | -975.8% | 618.9% | -219.8% |
| Return on equity | -685.6% | 173.8% | -222.0% | -360.6% | -78.9% | -30.0% | -249.0% | 233.7% | -62.3% | 49.4% |
| Current ratio | 1.61 | 4.52 | 3.22 | 2.35 | 6.91 | 7.61 | 0.32 | 0.10 | 0.33 | 0.86 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.